Institutional Manager · CIK 0001773195
Affinity Asset Advisors, LLC
New York, NY · File #028-20754
Latest AUM
$1.76B
Positions
95
Top-10 Concentration
47.4%
Filings
13
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Dec 202595 pos · $1.76B
- 13F HOLDINGS REPORTQ/E Sep 202596 pos · $1.15B
- 13F HOLDINGS REPORTQ/E Jun 202591 pos · $732.2M
- 13F HOLDINGS REPORTQ/E Mar 202598 pos · $1.05B
- 13F HOLDINGS REPORTQ/E Dec 202485 pos · $746.0M
- 13F HOLDINGS REPORTQ/E Sep 202486 pos · $732.8M
- 13F HOLDINGS REPORTQ/E Jun 202498 pos · $867.5M
- 13F HOLDINGS REPORTQ/E Mar 202495 pos · $807.8M
- 13F HOLDINGS REPORTQ/E Dec 202381 pos · $355.5M
- 13F HOLDINGS REPORT (Amended)Q/E Sep 202370 pos · $286.3M
- 13F HOLDINGS REPORTQ/E Sep 202371 pos · $286.8M
- 13F HOLDINGS REPORTQ/E Jun 202374 pos · $303.0M
- 13F HOLDINGS REPORTQ/E Mar 202363 pos · $255.0M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | SPDR SERIES TRUST | 78464A870 | 1,500,000 | $182.9M | 11.45% |
| 2 | APOGEE THERAPEUTICS INC | APGE | 1,234,926 | $93.2M | 5.84% |
| 3 | INSMED INC | INSM | 450,000 | $78.3M | 4.90% |
| 4 | ABIVAX SA | AAVXF | 505,000 | $68.1M | 4.26% |
| 5 | ISHARES TR | 464287556 | 400,000 | $67.5M | 4.23% |
| 6 | VENTYX BIOSCIENCES INC | 92332V107 | 6,484,558 | $58.6M | 3.67% |
| 7 | XENON PHARMACEUTICALS INC | XENE | 1,250,000 | $56.0M | 3.51% |
| 8 | PRAXIS PRECISION MEDICINES I | PRAX | 185,000 | $54.5M | 3.41% |
| 9 | CYTOKINETICS INC | CYTK | 800,000 | $50.8M | 3.18% |
| 10 | SPYRE THERAPEUTICS INC | SYRE | 1,432,591 | $46.9M | 2.94% |
| 11 | WAVE LIFE SCIENCES LTD | WVE | 2,700,000 | $45.9M | 2.87% |
| 12 | AMGEN INC | AMGN | 135,000 | $44.2M | 2.77% |
| 13 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 1,400,000 | $43.7M | 2.74% |
| 14 | SELECT SECTOR SPDR TR | 81369Y209 | 250,000 | $38.7M | 2.42% |
| 15 | ROIVANT SCIENCES LTD | ROIV | 1,700,000 | $36.9M | 2.31% |
| 16 | ARCELLX INC | ACLX | 523,725 | $34.1M | 2.14% |
| 17 | NUVALENT INC | NUVL | 322,633 | $32.5M | 2.03% |
| 18 | LEXEO THERAPEUTICS INC | LXEO | 3,200,000 | $31.8M | 1.99% |
| 19 | ALKERMES PLC | ALKS | 1,000,000 | $28.0M | 1.75% |
| 20 | FORTE BIOSCIENCES INC | FBRX | 989,490 | $27.0M | 1.69% |